Table 1

Patient characteristics by quartile of serum 25-hydroxyvitamin D

Serum 25-hydroxyvitamin D quartile
Q1
(10–44 nmol/L)
Q2
(45–64 nmol/L)
Q3
(65–87 
nmol/L)
Q4
(88–658 nmol/L)
P for linear trend
N18 05318 02218 05618 040
Serum 25-hydroxyvitamin D, median, mean (SD)33, 31 (8.5)55, 55, (5.8)75, 75 (6.4)105, 114 (29.6)
Age, years, mean (SD)48 (15)51 (15)54 (15)58 (15)<0.001
% Male, (n)56.3 (10 166)51.4 (9261)45.4 (8199)40.1 (7218)<0.001
BMI, kg/m2, mean (SD)27.4 (5.3)27.3 (5.1)26.9 (5.1)26.1 (4.8)<0.001
Daylight hours during month of testing, mean (SD)11.9 (2.9)12.2 (2.9)12.4 (2.9)12.5 (2.9)<0.001
Census dissemination area-level measures of socioeconomic status
Canadian citizens, mean % (SD)88.1 (10.1)89.8 (8.9)91.0 (8.1)91.9 (7.5)<0.001
Recent immigrants, mean % (SD)33.4 (16.8)30.0 (16.2)27.4 (15.1)25.2 (13.8)<0.001
Visible minorities, mean % (SD)38.5 (26.0)32.4 (24.9)27.8 (22.6)23.6 (19.9)<0.001
Do not speak official language (English or French) at home, mean % (SD)39.4 (22.1)34.5 (21.1)31.0 (19.6)27.7 (17.3)<0.001
Aboriginal identity, mean % (SD)2.5 (5.7)2.2 (4.4)2.1 (4.2)2.0 (4.1)<0.001
Postsecondary education, mean % (SD)54.8 (14.0)56.9 (13.6)58.7 (13.5)60.2 (12.9)<0.001
Employed, mean % (SD)93.3 (5.7)93.5 (5.8)93.7 (5.5)93.9 (5.2)<0.001
Household total income, CDN$, median (SD)85 434 (32 435)90 779 (35 727)944 486 (38 827)96 986 (41 439)<0.001
All cancer, n6157379281159<0.001
 Major cancer, n264381470604<0.001
  Breast cancer, n83125127183<0.001
  Colorectal cancer, n576891101<0.001
  Lung cancer, n30445761<0.001
  Prostate cancer, n638077110<0.001
  Skin cancer, n (non-melanoma/melanoma)31 (5/26)64 (15/49)118 (17/101)149 (21/128)<0.001
 Other cancer, n351356458555<0.001
  • There were 2849 census dissemination areas.

  • BMI, body mass index.